INTRA CELLULAR THERAPIES INC's ticker is ITCI and the CUSIP is 46116X101. A total of 141 filers reported holding INTRA CELLULAR THERAPIES INC in Q2 2016. The put-call ratio across all filers is 0.49 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2016 | $295,000 | +39.8% | 7,600 | 0.0% | 0.12% | +34.1% |
| Q1 2016 | $211,000 | -48.4% | 7,600 | 0.0% | 0.09% | -23.5% |
| Q4 2015 | $409,000 | -95.0% | 7,600 | -96.3% | 0.12% | -92.7% |
| Q3 2015 | $8,235,000 | -28.2% | 205,657 | -42.7% | 1.58% | +45.8% |
| Q2 2015 | $11,465,000 | +31.4% | 358,857 | -1.8% | 1.08% | +31.1% |
| Q1 2015 | $8,725,000 | +33.3% | 365,357 | -1.5% | 0.82% | +31.4% |
| Q4 2014 | $6,544,000 | +28.3% | 370,757 | -0.3% | 0.63% | +19.2% |
| Q3 2014 | $5,100,000 | -23.1% | 371,957 | -5.4% | 0.53% | -7.6% |
| Q2 2014 | $6,630,000 | -7.5% | 393,257 | -0.3% | 0.57% | -2.7% |
| Q1 2014 | $7,169,000 | – | 394,357 | – | 0.58% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sarissa Capital Management LP | 675,000 | $26,203,000 | 7.44% |
| EcoR1 Capital, LLC | 244,950 | $9,509,000 | 3.75% |
| Redmile Group, LLC | 971,565 | $37,716,000 | 3.60% |
| Ghost Tree Capital, LLC | 120,000 | $4,658,000 | 1.34% |
| SENZAR ASSET MANAGEMENT, LLC | 144,624 | $5,614,304,000 | 1.22% |
| GREAT POINT PARTNERS LLC | 100,000 | $3,882,000 | 1.11% |
| BB BIOTECH AG | 700,000 | $27,174,000 | 1.07% |
| Rhenman & Partners Asset Management AB | 115,000 | $4,464,000 | 0.79% |
| Lisanti Capital Growth, LLC | 12,260 | $476,000 | 0.72% |
| Rock Springs Capital Management LP | 190,000 | $7,376,000 | 0.55% |